Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Times Interest Earned (2016 - 2025)

Amphastar Pharmaceuticals has reported Times Interest Earned over the past 13 years, most recently at -$11.89 for Q4 2025.

  • Quarterly results put Times Interest Earned at -$11.89 for Q4 2025, down 269.23% from a year ago — trailing twelve months through Dec 2025 was $1.02 (down 84.95% YoY), and the annual figure for FY2025 was $1.02, down 84.95%.
  • Times Interest Earned for Q4 2025 was -$11.89 at Amphastar Pharmaceuticals, down from $4.03 in the prior quarter.
  • Over the last five years, Times Interest Earned for AMPH hit a ceiling of $144.36 in Q4 2021 and a floor of -$11.89 in Q4 2025.
  • Median Times Interest Earned over the past 5 years was $9.38 (2023), compared with a mean of $39.35.
  • Biggest five-year swings in Times Interest Earned: soared 341.24% in 2021 and later plummeted 269.23% in 2025.
  • Amphastar Pharmaceuticals' Times Interest Earned stood at $144.36 in 2021, then crashed by 50.37% to $71.65 in 2022, then crashed by 92.03% to $5.71 in 2023, then grew by 23.08% to $7.03 in 2024, then tumbled by 269.23% to -$11.89 in 2025.
  • The last three reported values for Times Interest Earned were -$11.89 (Q4 2025), $4.03 (Q3 2025), and $6.72 (Q2 2025) per Business Quant data.